• SENSEX 76,421.99
    -195.45 (--0.26%)
  • BANKNIFTY 51,348.05
    520.55 (+1.02%)
  • Tejas Networks
    902.70 1,495.10(%)
  • Mazagon Dock
    2,716.00 2,929.98(%)
  • Adani Power
    538.00 896.75(%)
  • Kalyan Jewellers
    497.15 337.00(%)
  • Hind.Aeronautics
    4,305.95 5,675.00(%)
  • TCS
    3,416.60 3,457.35(%)
  • Reliance Industr
    1,234.55 1,156.00(%)
  • Bharat Electron
    288.30 340.35(%)
  • Vodafone Idea
    8.06 6.60(%)
  • Tata Motors
    655.20 606.20(%)
  • Zydus Lifesci.
    949.85 1,323.90(%)
  • IndusInd Bank
    714.65 1,576.00(%)
  • Zomato Ltd
    214.00 304.50(%)
  • Reliance Power
    44.44 54.25(%)
  • ICICI Pru. BSE
    1,000.00 998.75(%)
  • Aurobindo Pharma
    1,267.95 1,592.55(%)
  • Piramal Enterp.
    977.85 736.60(%)
  • Persistent Sys
    4,826.65 3,232.60(%)
  • HDFC Bank
    1,799.50 1,880.00(%)
  • Wockhardt
    1,424.20 489.20(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Raymed Labs Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 5975.0
  • ISIN : INE741C01017
3.17 0 (4.97%)
  • As on 03 Apr 2025 (EOD)

  • Today’s Low

    3.17

  • Today’s High

    3.17

  • Open

    3.17

  • Perv Close

    3.02

  • 52W Low

    2.28

  • 52W High

    3.17

Key Indicators

  • P/E(TTM)

    0.00

  • Mar.Cap (₹Cr.)

    1.35

  • Div & Yield %

    0.00

  • Book Value(₹)

    -6.31

  • Debt-Equity Ratio

    4.97

  • AGM Date

    24-Mar-2025

  • EPS

    0.00

  • P/E Ratio

    0.00

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    1.35

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    4.27

  • BV (₹)

    -6.30

  • Sales( ₹ in Cr.)

    0.00

  • NP (in Cr.)

    -0.10

  • NP Var(%)

    41.0

  • Div%

    0.0

  • CPS (₹)

    -0.20

  • EPS (₹)

    -0.20

  • Traded Value (₹ in Lakhs)

    1.35

  • 52 Week High

    3.17

  • 52 Week Low

    2.28

  • Price BSE

    3.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    1.35

  • P/C Ratio

    -13.20

  • P/E Ratio

    -12.60

  • Price Vs.BV

    -0.20

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Sales Turnover 0.00 0.00 0.00 0.00 0.00 0.00
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 0.00 0.00 0.00 0.00 0.00 0.00
Other Income 0.00 0.02 0.00 0.01 0.01 0.01
Stock Adjustments 0.00 0.00 0.00 0.00 0.00 0.00
Total Income 0.00 0.02 0.00 0.01 0.01 0.01
EXPENDITURE :
Raw Materials 0.00 0.00 0.00 0.00 0.00 0.00
Power & Fuel Cost 0.00 0.00 0.00 0.00 0.00 0.00
Employee Cost 0.04 0.04 0.03 0.02 0.02 0.01
Other Manufacturing Expenses 0.00 0.09 0.00 0.00 0.00 0.00
Selling & Administrative Expenses 0.06 0.06 0.05 0.05 0.05 0.02
Miscellaneous Expenses 0.00 0.09 0.00 0.00 0.00 0.00
Less : Pre-operative Expenses Capitalised :
Total Expenditure 0.10 0.19 0.08 0.08 0.07 0.04
Operating Profit 0.00 0.00 0.00 0.00 0.00 0.00
Interest 0.00 0.00 0.00 0.00 0.00 0.00
Gross Profit -0.10 -0.17 -0.08 -0.07 -0.06 -0.05
Depreciation 0.00 0.01 0.01 0.01 0.01 0.01
Profit Before Tax -0.10 -0.17 -0.08 -0.07 -0.06 -0.05
Tax 0.00 0.00 0.00 0.00 0.00 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00
Reported Net Profit -0.10 -0.17 -0.08 -0.07 -0.06 -0.05
Extraordinary Items -0.10 -0.17 -0.08 -0.07 -0.06 -0.05
Adjusted Net Profit -0.10 -0.17 -0.08 -0.07 -0.06 -0.05
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 0.00 0.00 0.00 0.00 0.00 0.00
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down -0.10 -0.17 -0.08 -0.07 -0.06 -0.05
Dividend - - - - - -
Preference Dividend - - - - - -
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr -0.24 -0.40 -0.19 -0.16 -0.13 -0.13
Book Value 0.00 0.00 0.00 0.00 0.00 0.00
Book Value(Adj)-Unit Curr 0.00 0.00 0.00 0.00 0.00 0.00

Shareholding Pattern

  • Promoter Group

    28.36%

  • Public Share Holding

    71.64%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 1,212,050 28.36 1,212,050 1
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 1,212,050 28.36 1,212,050 1
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 41,000 0.96 0 1
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 41,000 0.96 0 1
2] Non Institution
Bodies Corporate 682,452 15.97 659,552 43
Clearing Members 50 0.00 50 1
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 57,501 1.35 45,301 14
Foreign Non Institution Other 200,000 4.68 0 1
Hindu Undivided Families 35,233 0.82 35,233 13
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 706,791 16.54 662,791 11
Individuals holding nominal share capital up to Rs. 1 lakh 1,338,423 31.32 871,173 1,409
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 3,020,450 70.68 2,274,100 1,492
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 4,273,500 100.00 3,486,150 1,494

Company Background

Raymed Labs LtdPharmaceuticals - Indian - Formulations

  • Raymed Labs Ltd
  • BSE Code : 5975.0
  • ISIN : INE741C01017

  • Incorporation Year

    1992

  • Registered Office

    103 Emperor 1 Sector 93A
    Supertech Emerald Court, Noida,
    Uttar Pradesh-201304

  • Telephone

    91-0120-2426900/9412700300

  • FAX

  • Chairman

  • Managing Director

    Prashant Nathmal Bajaj

  • Company Secretary

  • Auditor

    A Kay Mehra & Co/KTPS & Co.

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Beetal Fin.& Comp. Ser.(P) Ltd
    Beetal House 99 ,
    Madangir Behind LSC ,Nr Dada Harsukhdar
    Mumbai - Delhi - 110062

Raymed Labs Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Raymed Labs 3.17 0.00 0.00 -4.01 0.00
Abbott India 29,572.60 6,097.18 5,848.91 47.09 44.71
Astrazeneca Phar 8,100.10 1,330.33 1,295.53 208.82 33.26
P & G Health Ltd 5,259.35 1,166.89 1,151.26 36.90 39.76
Glaxosmi. Pharma 2,776.60 3,530.73 3,407.25 55.21 44.44
Cipla 1,452.70 17,645.00 16,574.34 24.90 20.10
Amrutanjan Healt 645.10 437.58 421.23 37.81 20.84
Fermenta Biotec. 292.05 315.24 307.09 27.68 4.10
Guj. Themis Bio. 272.20 174.19 169.82 56.36 44.82
Bliss GVS Pharma 120.00 638.96 605.46 27.46 11.19
Ambalal Sarabhai 37.31 11.70 3.81 15.94 1.92